The pharmaceutical value chain model depicted in Figure 1 covers a full range of activities that are required to bring a product from conception to final consumer. The key players in the chain are ...

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.

Across the pharmaceutical value chain – from research and development to manufacturing and distribution – users must be equipped with the knowledge and skills required to navigate complex ...

and commercial functions to ensure seamless execution across the value chain. In addition, pharmaceutical companies should focus on elevating business acumen, diagnostic capabilities, and ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

"The measures noted above not only improve manufacturing operations, but also play a role in making the entire pharmaceutical value chain more sustainable, with CPOs leading the way," von Kienlin ...

Impacts of tariffs on the pharmaceutical industry, cutting-edge container monitoring and the sheer number of chicken wings ...

Respondents also considered target identification to be the component of the pharmaceutical value chain most set to benefit from the incorporation of AI. This was followed by lead generation and ...

We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of ...